Pura Vida Investments’s Medpace MEDP Stock Holding History

Pura Vida Investments’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-70,000	Closed	-$2.54M	–	87
2017 Q4	$2.54M	Buy	+70,000	New	+$2.45M	1.06%	39
2017 Q2	–	Sell	-145,282	Closed	-$4.34M	–	83
2017 Q1	$4.34M	Buy	145,282 +42,775	+42%	+$1.38M	1.28%	37
2016 Q4	$3.7M	Sell	102,507 -55,921	-35%	-$1.86M	1.36%	30
2016 Q3	$4.73M	Buy	+158,428	New	+$4.63M	1.44%	26

Other funds holding MEDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pura Vida Investments's MEDP Position: Q1 2018 in Review

Pura Vida Investments sold out of Medpace (MEDP) in Q1 2018, closing a stake of 70,000 shares — an estimated $2.54M sold.

Pura Vida Investments first reported a position in MEDP in Q3 2016 and held it in 4 quarters. The position peaked at $4.73M in Q3 2016. 113 funds tracked by Wall St. Rank hold MEDP as of Q1 2018.

Pura Vida Investments reported no remaining Medpace position as of Q1 2018 after selling out during the quarter.
Pura Vida Investments sold 70,000 Medpace shares in Q1 2018, an estimated $2.54M.
Pura Vida Investments first reported a position in Medpace in Q3 2016 and held it in 4 quarters.
Pura Vida Investments's Medpace position peaked at $4.73M in Q3 2016.
113 funds tracked by Wall St. Rank held Medpace as of Q1 2018.

Based on Pura Vida Investments's 13F filing for Q1 2018, filed 14 May 2018.